XML 162 R118.htm IDEA: XBRL DOCUMENT
v3.19.3.a.u2

Segments - Summary of Profit by Segments and Reconciliation of Segments Profit to Consolidated Income Before Income Taxes (Detail) - USD ($) $ in Millions | 12 Months Ended
--- | ---
Dec. 31, 2019 | Dec. 31, 2018 | Dec. 31, 2017
Amounts allocated to segments: |  |  |  |  |
Segments profit |  | $ (443) | $ (1,637) |  | $ (17,484)
Amounts not allocated to segments: |  |  |  |  |
Amortization |  | 1,113 | 1,166 |  | 1,444
Other assets impairments, restructuring and other items |  | 423 | 987 |  | 1,836
Goodwill impairment |  |  | 3,027 | [1] | 17,100
Intangible asset impairments |  | 1,639 | 1,991 |  | 3,238
Gain on divestitures, net of divestitures related costs |  | (50) | (66) |  | (1,083)
Inventory step-up |  |  |  |  | 67
Other R&D expenses (income) |  | (15) | 83 |  | 221
Costs related to regulatory actions taken in facilities |  | 45 | 14 |  | 47
Legal settlements and loss contingencies |  | 1,178 | (1,208) |  | 500
Other unallocated amounts |  | 252 | 366 |  | 187
Consolidated operating income (loss) |  | (443) | (1,637) |  | (17,484)
Financial expenses, net |  | 822 | 959 |  | 895
Consolidated income (loss) before income taxes |  | (1,265) | (2,596) |  | (18,379)
North America [Member] |  |  |  |  |
Amounts allocated to segments: |  |  |  |  |
Segments profit |  | 2,252 | 2,837 |  | 4,624
Amounts not allocated to segments: |  |  |  |  |
Consolidated operating income (loss) |  | 2,252 | 2,837 |  | 4,624
Europe [Member] |  |  |  |  |
Amounts allocated to segments: |  |  |  |  |
Segments profit |  | 1,318 | 1,273 |  | 1,029
Amounts not allocated to segments: |  |  |  |  |
Consolidated operating income (loss) |  | 1,318 | 1,273 |  | 1,029
International Markets [Member] |  |  |  |  |
Amounts allocated to segments: |  |  |  |  |
Segments profit | [2] | 464 | 498 |  | 426
Amounts not allocated to segments: |  |  |  |  |
Consolidated operating income (loss) | [2] | 464 | 498 |  | 426
Corporate Segment [Member] |  |  |  |  |
Amounts allocated to segments: |  |  |  |  |
Segments profit |  | 4,034 | 4,608 |  | 6,079
Amounts not allocated to segments: |  |  |  |  |
Consolidated operating income (loss) |  | 4,034 | 4,608 |  | 6,079
Other Segments [Member] |  |  |  |  |
Amounts allocated to segments: |  |  |  |  |
Segments profit |  | 108 | 115 |  | (6)
Amounts not allocated to segments: |  |  |  |  |
Consolidated operating income (loss) |  | 108 | 115 |  | (6)
Segments and Other Activities [Member] |  |  |  |  |
Amounts allocated to segments: |  |  |  |  |
Segments profit |  | 4,142 | 4,723 |  | 6,073
Amounts not allocated to segments: |  |  |  |  |
Consolidated operating income (loss) |  | $ 4,142 | $ 4,723 |  | $ 6,073
[1] | Goodwill impairment mainly attributable to the International Markets segment, Mexico and Medis.
[2] | The data presented for prior periods have been revised to reflect a revision in the presentation of net revenues and cost of sales in the consolidated financial statements. See note 1b.

X
- Definition Amounts allocated to segments. + References No definition available. + Details
Name: | teva_AmountsAllocatedToSegmentsAbstract
Namespace Prefix: | teva_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amounts not allocated to segments. + References No definition available. + Details
Name: | teva_AmountsNotAllocatedToSegmentsAbstract
Namespace Prefix: | teva_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Costs related to regulatory actions taken in facilities. + References No definition available. + Details
Name: | teva_CostsRelatedToRegulatoryActionsTakenInFacilities
Namespace Prefix: | teva_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Impairments restructuring and others. + References No definition available. + Details
Name: | teva_ImpairmentsRestructuringAndOthers
Namespace Prefix: | teva_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Inventory step up. + References No definition available. + Details
Name: | teva_InventoryStepUp
Namespace Prefix: | teva_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The net proceeds or assets obtained in excess of (less than) the net carrying amount of assets recorded, or assets distributed and liabilities assumed less than (in excess of) litigation reserves extinguished, in settlement of a litigation matter. Represents (for other than an insurance entity in its normal claims settlement process), the amount of income (expense) recognized in the period to settle pending or threatened litigation and insurance claims and the aggregate amount provided for estimated restructuring charges, remediation costs, and asset impairment loss during an accounting period. Generally, these items are either unusual or infrequent, but not both (in which case they would be extraordinary items). + References No definition available. + Details
Name: | teva_LegalSettlementsAndLossContingencies
Namespace Prefix: | teva_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Other unallocated amounts. + References No definition available. + Details
Name: | teva_OtherUnallocatedAmounts
Namespace Prefix: | teva_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Purchase of research and development in process. + References No definition available. + Details
Name: | teva_PurchaseOfResearchAndDevelopmentInProcess
Namespace Prefix: | teva_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a)(2) -URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585 + Details
Name: | us-gaap_AdjustmentForAmortization
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 2 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=108376223&loc=d3e13854-109267 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266 + Details
Name: | us-gaap_GoodwillImpairmentLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 3 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275 + Details
Name: | us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(h)(1)(i)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 + Details
Name: | us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.7) -URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227 + Details
Name: | us-gaap_NonoperatingIncomeExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The net result for the period of deducting operating expenses from operating revenues. + References No definition available. + Details
Name: | us-gaap_OperatingIncomeLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition This element represents the cash inflow during the period from the sale of a component of the entity. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 12 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3179-108585 + Details
Name: | us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=teva_NorthAmericaSegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=teva_EuropeSegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=teva_InternationalMarketsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=teva_SegmentsAndOtherActivitiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |